ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
63.915,37
1,63%
Brent Oil
82,765
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) Notícias

NYMX

Nymox Pharmaceutical (NYMX)

Nymox Pharmaceutical Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NYMX
DataHoraFonteTítuloCódigoCompanhia
28/03/202414:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
08/09/202311:13Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NYMXNymox Pharmaceutical Corp
25/07/202311:33GlobeNewswire Inc.Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial ResultsNASDAQ:NYMXNymox Pharmaceutical Corp
18/07/202311:45GlobeNewswire Inc.Nymox Reports on U.S. Patent IssuancesNASDAQ:NYMXNymox Pharmaceutical Corp
13/07/202311:16GlobeNewswire Inc.Nymox UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
12/07/202310:30GlobeNewswire Inc.Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxNASDAQ:NYMXNymox Pharmaceutical Corp
07/07/202318:02GlobeNewswire Inc.NYMOX UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
05/07/202319:11GlobeNewswire Inc.Nymox Delisting from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202318:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202317:25Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202317:24Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:NYMXNymox Pharmaceutical Corp
26/06/202311:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
10/05/202311:00GlobeNewswire Inc.Nymox Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
03/04/202310:30GlobeNewswire Inc.Nymox Provides Corporate UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
31/03/202317:25Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:NYMXNymox Pharmaceutical Corp
21/03/202311:00GlobeNewswire Inc.Nymox Announces Appointment of Christopher R. Riley as Chief Financial OfficerNASDAQ:NYMXNymox Pharmaceutical Corp
15/03/202310:30GlobeNewswire Inc.Nymox Officially Granted Extension to Regain Listing RequirementsNASDAQ:NYMXNymox Pharmaceutical Corp
15/02/202313:50GlobeNewswire Inc.Nymox Announces NYMOZARFEX Marketing Application is Accepted For ReviewNASDAQ:NYMXNymox Pharmaceutical Corp
06/01/202318:30GlobeNewswire Inc.NYMOX Appeals Deficiency LetterNASDAQ:NYMXNymox Pharmaceutical Corp
05/12/202211:30GlobeNewswire Inc.NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPHNASDAQ:NYMXNymox Pharmaceutical Corp
25/11/202217:10GlobeNewswire Inc.May 2023 Market Cap Requirement UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
13/09/202210:30GlobeNewswire Inc.NYMOX Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
15/07/202210:30GlobeNewswire Inc.NYMOX Updates ShareholdersNASDAQ:NYMXNymox Pharmaceutical Corp
14/07/202213:18GlobeNewswire Inc.NYMOX Receives Deficiency Letter from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
23/05/202209:30GlobeNewswire Inc.NYMOX Receives RTF letter from FDANASDAQ:NYMXNymox Pharmaceutical Corp
06/05/202207:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NYMXNymox Pharmaceutical Corp
13/04/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NYMXNymox Pharmaceutical Corp
04/04/202210:45GlobeNewswire Inc.Nymox Announces Closing of $6.4 Million FinancingNASDAQ:NYMXNymox Pharmaceutical Corp
22/03/202215:57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NYMXNymox Pharmaceutical Corp
18/03/202209:30GlobeNewswire Inc.Nymox Announces $5 Million Registered Direct OfferingNASDAQ:NYMXNymox Pharmaceutical Corp
 Apresentando as notícias mais relevantes sobre:NASDAQ:NYMX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HOOT4
HOTEIS OTHON PN
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados